Applications published 28 March 2007

Analogues of dictoystatin, intermediates therefore and methods of synthesis thereof
University of Pittsburgh 1765073*

Positionally modified siRNA constructs
Isis Pharmaceuticals 1765074*

Pyrimidines, such as urindine, in treatments for patients with bipolar disorder
The McLean Hospital Corp 1765075*

Compsns and formulations of decitabine polymorphs and methods of use thereof
SuperGen 1765076*

Use of 3-(2,4,6-trimethylphenyl)-
4-neopentylcarbonyloxy-
5,5-tetramethylene-N-
dihydrofuran-2-on for controlling psyllidae
Bayer CropScience 1765077*

Drug candidate selection by hydrogen exchange characterisation of ligand-induced receptor confirmation
Exsar Corp 1765078*

Use of IL-17 in the treatment of fertility-related disorders
Applied Research Systems 1765083*

Compsns comprising female germline stem cells and methods of use thereof
The General Hospital Corp 1765085*

Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation
Biogaia 1765282*

Pharmaceutical compsns
Vertex Pharmaceuticals 1765283*

Retinoid-containing sustained release intraocular drug delivery systems and related methods of manufacturing
Allergan 1765284*

Poly (lactic acid) copolymer hydrogels and related methods of drug delivery
University of Massachusetts 1765285*

Pharmaceutically elegant, topical anhydrous aerosol foam
DPT Laboratories 1765286*

Immediate release formulations of memantine oral dosage forms
Merz Pharma 1765287*

Methods of treatment of endobronchial infections
Novartis Vaccines and Diagnostics; Nektar Therapeutics 1765288*

Compsns and methods for stabilising lipid-based adjuvant formulations using glycolipids
Statens Serum Institut 1765289*

Stabilised supersaturated solid solutions of steroidal drugs
Schering 1765290*

Enhanced medical product
Mederio 1765291*

Abuse-deterrent drug formulations
Collegium Pharmaceutical 1765292*

Pharmaceutical compsns for drug delivery and methods for treating or preventing conditions using same
Idexx Laboratories 1765293*

Nucelic acid microspheres, production and delivery thereof
Baxter International; Baxter Healthcare 1765294*

Sustained-release compsn, process for producing the same and use of the same
Takeda Pharmaceutical Company 1765295*

High ibuprofen content granules and their preparation and use
Albemarle Corp 1765296*

Porous tablets as carriers for liquid formulations
LifeCycle Pharma 1765297*

Method for producing a solid dosage form, which is safeguarded against abuse, while using a planetary gear extruder
Gruenenthal 1765298*

Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight
RP Scherer Technologies 1765299*

Formulations of sumitriptan for absorption across biological membranes, and methods of making and using the same
Duramed Pharmaceuticals 1765300*

Prosthetic device having drug delivery properties
Endovasc 1765301*

Optically controlled microfluidic chip
The Board of Trustees of the Leland Stanford Junior University 1765302*

Oral dosage form safeguarded against abuse
Gruenenthal 1765303*

Compressed chewing gum tablet
Gumlink 1765304*

Controlled phase compsn technology as an improved process for protection of drugs
Drugtech 1765305*

Capsule for release agents contained therein at defined points in a body
Faschhochschule Jena 1765306*

Dry coating process
Mepha 1765307*

Antimicrobial dental formulations for the prevention and treatment of oral mucosal disease
Rosen, Gerald 1765308*

A mixture for transdermal delivery of low and high molecular weight compounds
Oryxe 1765310*

Reducing nephropathy with inhibitors of soluble epoxide hydrolase and epoxyeicosanoids
The Regents of the University of California 1765311*

Treatment of diseases associated with the use of antibiotics
Optimer Pharmaceuticals 1765312*

Compounds for immunopotentiation
Novartis Vaccines and Diagnostics 1765313*

Pharmaceutical compsns for the treatment of disease and/or symptoms in arthritis
GW Pharma 1765314*

Abnormal cannabidiols for lowering intraocular pressure
Allergan 1765315*

Methods and compsns for modulating BAX-KU70-mediated apoptosis
The President and Fellows of Harvard College 1765316*

Medium chain fatty acids applicable as anti-microbial agents
Nutrition Sciences 1765318*

Essential fatty acids in the prevention and/or treatment in patients with coronary heart or artery disease
Solvay Pharmaceutical 1765319*

Antimicrobial compsns and methods of use thereof
Nocipharm 1765321*

Retinal derivatives and methods for the use thereof for the treatment of visual disorders
University of Washington 1765322*

Use of furan alkyl for preparing an antidiabetic drug
Laboratoires Expanscience 1765323*

Compsns of stable bioactive metabolites of docosahexanoic (DHA) and eicosapentaenoic acids
Natreon 1765324*

2-substituted heteroaryl compounds
Synta Pharmaceuticals 1765325*

Carbapenem antibacterials with gram-negative activity and processes for their preparation
FOB Synthesis 1765326*

Compounds, compsns and methods
Cytokinetics 1765327*

Anticancer compsn comprising proline or its derivatives and an anti-tumour antibody
Salama, Zoser 1765328*

Indoles having anti-diabetic activity
Merck 1765329*

Pyranoindole derivatives and the use thereof for the treatment of hepatitis C virus infection or disease
Viropharma; Wyeth 1765330*

Methods and compsns for the treatment of pulmonary diseases
Sepracor 1765331*

Trisubstituted nitrogen modulators of tyrosine phosphatases
Cengent Therapeutics 1765332*

Method for inhibiting tumour metastasis
Inflammation Research Centre 1765333*

Prodrugs of mitotic kinesin inhibitors
Merck 1765334*

Pyrazole amide derivatives, compsns containing such compounds and methods of use
Merck 1765335*

Angiogenesis inhibitors
The Johns-Hopkins University 1765336*

Combination of anti-HIV reverse transcriptase and protease inhibitors
Tibotec Pharmaceuticals 1765337*

Methods for inducing anti-anxiety and calming effects in animals and humans
Seroctin Research & Technologies 1765338*

Muscarinic acetylcholine receptor antagonists
Glaxo Group 1765339*

Sustained oral release compsns for oral administration of niacin
Hanmi Pharm 1765340*

Methods of treating cellular proliferative disease using naphthalamide and PARP-1 inhibitors
ChemGenex Pharmaceuticals 1765341*

Pharmaceutical compsn comprising amlodipine besilate and lisinopril dihydrate and process for the preparation thereof
Richter Gedeon Vegyeszeti Gyar1 1765342*

Use of 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines in the treatment of nausea and vomiting
Bayer HealthCare 1765343*

Cancer treatment method
SmithKline Beecham 1765344*

A pharmaceutical compsns having prokinetic effect and comprising O-(3-piperidino-2-hydroxy-propyl) nicotinic amidoxide
N-Gene Research Laboratories 1765345*

Enhancement of anti-androgenic activity by a combination of inhibitors targeting different steps of a steroid-dependent gene activation pathway and uses thereof
AndroScience Corp 1765346*

Compounds having activity in increasing ion transport by mutant-CFTR and uses thereof
The Regents of the University of California 1765347*

Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
3M Innovative Properties Company 1765348*

Opioids for the treatment of chronic obstructive pulmonary disease
Euro-Celtique 1765349*

Manufacturing method of solid dispersion containing itrazoconazole
CTC Bio 1765350*

Protein kinase inhibitors
Oncalis 1765351*

Antagonising an adenosine A2A receptor to ameliorate one or more components of addictive behaviour
The Regents of the University of California 1765352*

Solid orally ingestible formulations of tetrodotoxin
Wex Pharmaceuticals 1765353*

Leptomycin compounds
Kosan Biosciences 1765354*

Benzoxazine for treating respiratory tract diseases
Boehringer Ingelheim International 1765355*

Spray compsn comprising a combination of calcitriol and clobetasol propionate, an alcoholic phase, at least one volatile silicone and one non-volatile oily phase
Galderma 1765356*

Use of ATP analogues for treatment of cardiovascular diseases
Institut National de la Sante et de la Recherche Medicale 1765357*

Treatment of prevention of skin conditions or tissue conditions in animals using boryloxypyridinyl-methanones
Anacor Pharmaceuticals 1765358*

Antibiotics containing borinic acid complexes and methods of use
Anacor Pharmaceuticals 1765359*

Antiviral uses of borinic acid complexes
Anacor Pharmaceuticals 1765360*

Products containing at least one anticancer active principle with low diffusion and an immunostimulatory active principle
Institut Gustave Roussy; Centre National de la Recherche Scientifique; Universite Rene Descartes 1765361*

Compsns and methods for treatment of neovascular diseases
The Scripps Research Institute 1765362*

New compsns
Glucogene Medical 1765363*

Pyrimidines, such as cytidine, in treatments for patients with bipolar disorders
The McLean Hospital Corp 1765364*

Compsns and methods for the co-delivery of anti-cancer drugs, anti-angiogenic drugs, and a polysaccharide
Pro-Pharmaceuticals 1765365*

Sulphated depolymerised derivatives of exopolysaccharides (EPS), preparation and uses thereof
Institut Francais de Recherche pour l'Exploration de la Mer; Universite Rene Descartes 1765366*

Phospholipid compsns and methods for their preparation and use
Chen Andrew-Xian 1765367*

Methods and compsns for wound healing
The Ohio State University Research Foundation 1765368*

Process for the preparation of calcium phosphate granules of the hydroxyapatite type
Innophos 1765369*

Parapoxviruses in combination with other antiviral agents for the treatment of HIV/AIDS
AiCurls 1765370*

Flavonol-based medicine for treating and/or preventing endoprosthetic restenosis and atheromatous disease in coronary patients
Societe Francaise de Distilleries 1765372*

Ozonidized pharmaceutical compsn and method
Stenti de Pirillo 1765373*

Compsns, methods and uses for a novel family of peptides
The Texas A&M University System 1765374*

Method for inhibiting angiogenesis
The Ludwig Institute for Cancer Research 1765375*

Topical compsns and methods for epithelial-related conditions
Signum Biosciences 1765376*

Medicament
Aimsco 1765377*

Agent capable of downregulating an MSF-A-dependent HIF-1A and use thereof in cancer treatment
Medical Research Foundation of Tel Aviv Sourasky Medical Centre 1765378*

Pharmaceutical co-crystal compsns and related methods of use
Transform Pharmaceuticals; University of South Florida 1765379*

Method of treating Parkinson's disease in humans by direct infusion of glial cell-line derived neurotrophic factor into the zona incerta
Streatfield, Gill Steven 1765380*

Treatment of neurological disorders with haematopoietic growth factors
Sygnis Bioscience 1765381*

Intranasal formulations of interferon beta free of stabilisers that are proteins or polypeptides
Nastech Pharmaceutical 1765382*

Use of hamlet (human alpha-lactalbumin made lethal to tumour cells) for treating viral infections
Hamlet Pharma 1765383*

Method of modulating cellular activity involving sphingosine kinase and agents for same, and sphingosine kinase variants
Medvet Pty 1765384*

Sustained release vaccine compsn
Smart Drug Systems 1765385*

Truncated hepatitis C virus NS5 domain and fusion proteins comprising same
Novartis Vaccines and Diagnostics 1765386*

Needle-free administration of FeLV vaccines
Merial 1765387*

Combination treatment for preventing or treating Alzheimer's disease, and kit therefor
Affiris Forschungs- und Entwicklungs 1765389*